Most patients in the UK drug trial experienced only mild side effects.
, which was available through a phase one safety trial at the Institute of Cancer Research in the UK.
He gave it a chance since his cancer continued to grow despite attempts at other treatments. Now, Wojkowski claims he’s been cancer-free for two years. RP2 involves a weakened form of herpes simplex — the virus that causes cold sores — that has been modified to only infect tumors. Unlike other cancer drugs, it is injected directly into the tumor.Once inside the body, the virus replicates itself until the cancer cell explodes. At the same time, it also rallies the immune system to attack what’s left,
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: